We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-0.47%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.27B
AUM Growth
-$622M
Cap. Flow
-$458M
Cap. Flow %
-10.71%
Top 10 Hldgs %
7.07%
Holding
1,383
New
78
Increased
507
Reduced
362
Closed
118

Top Buys

Rank Stock Value
1
DNOW icon
DNOW Inc
DNOW
+$10.8M
2
VTLE
Vital Energy
VTLE
+$9.28M
3
HTH icon
Hilltop Holdings
HTH
+$7.5M
4
PSFE icon
Paysafe
PSFE
+$7.41M
5
PINC
Premier
PINC
+$7.18M

Sector Composition

Rank Sector Weight
1 Financials 27.03%
2 Industrials 13.12%
3 Consumer Discretionary 12.97%
4 Technology 10.69%
5 Energy 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDSX icon
976
Biodesix
BDSX
$229M
$283K 0.01%
9,253
-2,230
-19% -$63.7K
FTK icon
977
Flotek Industries
FTK
$1.32B
$283K 0.01%
57,659
+10,000
+21% +$39.3K
VWOB icon
978
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.16B
$280K 0.01%
4,457
+25
+0.6% +$1.58K
SOND
979
DELISTED
Sonder
SOND
$278K 0.01%
60,000
CPHC icon
980
Canterbury Park Holding Corp
CPHC
$78.6M
$277K 0.01%
12,689
WYY icon
981
WidePoint Corp
WYY
$106M
$276K 0.01%
65,948
-23,200
-26% -$60.1K
RNAC icon
982
Cartesian Therapeutics
RNAC
$257M
$275K 0.01%
10,193
MLSS icon
983
Milestone Scientific
MLSS
$41.1M
$274K 0.01%
401,700
-100,000
-20% -$66.5K
DHX icon
984
DHI Group
DHX
$178M
$274K 0.01%
131,260
-97,120
-43% -$225K
ATXS
985
DELISTED
Astria Therapeutics
ATXS
$274K 0.01%
30,101
-5,000
-14% -$48.8K
RRGB icon
986
Red Robin
RRGB
$156M
$272K 0.01%
35,900
-400
-1% -$2.91K
RANI icon
987
Rani Therapeutics
RANI
$87.8M
$272K 0.01%
71,500
+20,000
+39% +$104K
OVID icon
988
Ovid Therapeutics
OVID
$495M
$271K 0.01%
352,170
-5,700
-2% -$15.9K
GROW icon
989
US Global Investors
GROW
$38.5M
$269K 0.01%
103,193
+3,600
+4% +$9.62K
TALK icon
990
Talkspace
TALK
$873M
$269K 0.01%
116,800
ABBV icon
991
AbbVie
ABBV
$431B
$267K 0.01%
1,559
SYRS
992
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$266K 0.01%
51,500
PED icon
993
PEDEVCO
PED
$142M
$263K 0.01%
14,562
+198
+1% +$3.61K
GLRE icon
994
Greenlight Captial
GLRE
$511M
$263K 0.01%
+20,088
New +$256K
BBLU icon
995
EA Bridgeway Blue Chip ETF
BBLU
$458M
$261K 0.01%
21,652
OPOF
996
DELISTED
Old Point Financial
OPOF
$257K 0.01%
17,504
-16,040
-48% -$236K
TACT icon
997
Transact Technologies
TACT
$58.4M
$256K 0.01%
68,000
+35,000
+106% +$147K
PRTS icon
998
CarParts.com
PRTS
$46.9M
$254K 0.01%
25,386
-3,678
-13% -$44.7K
GSIT icon
999
GSI Technology
GSIT
$254M
$251K 0.01%
94,717
+25,000
+36% +$81.5K
NPCE icon
1000
Neuropace
NPCE
$474M
$251K 0.01%
33,200

Similar funds

Bridgeway Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Bridgeway Capital Management held 1,383 positions worth $4.27B, down 13% from $4.89B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.

Bridgeway Capital Management withdrew a net $458M in Q2 2024, closing 118 positions and reducing 362 holdings. Its most notable exit was Netflix, an estimated $7.59M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Bridgeway Capital Management opened a new position in DNOW Inc worth $10.4M.

  • Bridgeway Capital Management's largest Q2 2024 buy was DNOW Inc: 758,458 shares worth $10.4M.
  • Bridgeway Capital Management added most to Vital Energy in Q2 2024, an estimated $9.28M increase.
  • Bridgeway Capital Management's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $17.7M.
  • Bridgeway Capital Management fully exited Netflix in Q2 2024, selling an estimated $7.59M.
  • Bridgeway Capital Management's ten largest holdings make up 7.1% of its $4.27B portfolio in Q2 2024.
  • Bridgeway Capital Management opened 78 new positions and closed 118 in Q2 2024.
  • Bridgeway Capital Management's portfolio value fell 13% quarter-over-quarter to $4.27B.

Based on Bridgeway Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.